Namwiwat Medical Corporation Public Company Limited

Namwiwat Medical Corporation Public Company Limited

3.28
THB
+0.14
(+4.46%)
0.14EPS
25.32P/E
2.39BMarket Cap
Nov 12Next Earn
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
1.42
1.57
1.79
1.59
2.67
2.41
Basic EPS, GAAP
- -
0.25
0.25
0.33
0.26
0.15
0.14
Free Cash Flow per Basic Share
- -
0.08
-0.26
0.34
-0.08
-0.04
- -
Dividend per Share
- -
- -
0.35
0.38
0.09
0.27
0.18
Book Value per Share
0.37
0.62
1.73
2.8
2.96
2.86
2.88
Tangible Book Value per Share
0.37
0.62
1.65
2.71
2.81
2.62
2.62
Basic Weighted Avg Shares
700
700
700
615
700
700
700
Sales/Revenue/Turnover
- -
992
1,099
1,101
1,114
1,870
1,688
Operating Margin (%)
- -
23.22
20.29
22.7
19.05
8.34
7.12
Depreciation Expense
- -
18
21
30
38
72
80
Net Income, GAAP
- -
175
176
201
181
102
95
Effective Tax Rate (%)
- -
20.16
20.82
19.79
21.18
18.6
21.23
Profit Margin (%)
- -
17.6
15.98
18.24
16.23
5.43
5.6
Working Capital
80
218
886
1,588
1,573
1,467
1,442
LT Debt
155
135
106
82
55
136
124
Total Equity
260
434
1,210
1,963
2,095
2,103
2,110
Return on Invested Capital (%)
- -
23.86
16.04
11.58
7.77
5.29
4.1
Return on Capital (%)
- -
23.94
16
11.63
8.14
4
4.18
Return on Common Equity (%)
- -
50.35
21.37
12.65
8.97
4.99
4.69

Capital Structure

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
359
338
348
LT Borrowings
89
81
74
LT Finance Leases
47
54
50
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
700
700
700
Market Capitalization
2,450
2,590
2,394

Working Capital

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
2,222
2,044
2,050
Cash, Cash Equivalents & STI
699
678
688
Accounts Receivable, Net
598
533
484
Inventories
825
710
744
Total Current Liabilities
756
586
608
Payables & Accruals
362
212
215
ST Debt
359
338
348
Deferred Revenue
30
32
40

Growth Rates

THB

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
63.06%
0.34%
Free Cash Flow
- -
- -
-44.94%
Net Income, GAAP
- -
- -
-43.83%
Sales/Revenue/Turnover
- -
- -
67.79%
Total Cash Common Dividend
- -
- -
196.89%

Quarterly Revenue

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
200
226
317
371
1,114
2025
538
389
487
455
1,870
2026
377
369
- -
- -
- -

Quarterly Earnings Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.02
0.06
0.1
0.08
0.26
2025
0.09
0.02
0.03
0.04
0.15
2026
0.02
0.04
- -
- -
- -

Quarterly Dividends Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.09
2025
- -
0.14
0.01
0.12
0.27
2026
0.02
0.03
- -
- -
- -

Company Description

CEO
Viroj Chaiterdkiat
Sector
Health technology
Industry
Medical specialties
Address
Phra Samut Chedi Thailand
IPO Date
Oct 31, 2023
Business
Namwiwat Medical Corporation Public Company Limited manufactures, distributes, and services medical cleaning, disinfection, and sterilization equipment, medical supplies, and healthcare waste treatment systems in Thailand and internationally. The company operates through three primary business segments: Manufacture and Sale of Medical Equipment; Sale of Medical Supplies and Consumables; and Healthcare Services and Turnkey Engineering Solutions. Its core product portfolio comprises steam autoclaves, low-temperature hydrogen peroxide gas plasma sterilizers, ethylene oxide gas sterilizers, washer-disinfectors, automated ultrasonic cleaning units, medical drying cabinets, pure steam generators, and on-site infectious medical waste treatment systems; medical consumables and single-use supplies, including sterilization pouches, wrapping fabrics, chemical indicator strips, biological indicators, enzymatic cleaning detergents, surgical instruments, and personal protective equipment; and specialized software, including central sterile supply department traceability and workflow management systems. Additionally, the company provides turnkey architectural and engineering services for sterile processing department design, cleanroom construction, and facility renovation; equipment maintenance, calibration, validation, and repair services; and outsourced hospital sterilization and medical waste management operations. The company serves public and private hospitals, specialized medical clinics, dental practices, veterinary hospitals, laboratories, and pharmaceutical manufacturers across Thailand and Southeast Asia. Founded in 1970 and headquartered in Samut Prakan, Thailand, the company was formerly known as Namwiwat Medical Corporation Co., Ltd. before converting to a public company and listing its shares on the Stock Exchange of Thailand under the ticker NAM. In recent developments, the company completed its initial public offering on the Stock Exchange of Thailand to finance production facility expansions and international distribution capabilities; established a strategic partnership with Innobic (Asia) Company Limited, the life science subsidiary of PTT Public Company Limited, to accelerate medical device innovation and regional commercialization; expanded its product portfolio with next-generation automated medical waste treatment technologies; and broadened its distribution network across Southeast Asian markets.